Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course

Bone Marrow Transplantation

Volumn 32, Issue 3, 2003, Pages 287-291

  Chang, C C ^a   Bredeson, C ^a   Juckett, M ^a   Logan, B ^a   Keever Taylor, C A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Clinical course; Follicular lymphoma; Quantitative PCR; Relapse; RQ PCR; SCT; Tumor load

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; HYDROXYUREA; IFOSFAMIDE; MELPHALAN; METHOTREXATE; MITOXANTRONE; PREDNISONE; PROCARBAZINE; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOPRESERVATION; FEMALE; FISHER EXACT TEST; FOLLICULAR LYMPHOMA; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; WHOLE BODY RADIATION;

ADULT; DISEASE PROGRESSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSLOCATION, GENETIC;

EID: 0043171049     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704130     Document Type: Article

References (17)

1. Juckett M, Rowlings P, Hessner M et al. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. Bone Marrow Transplant 1998; 21: 893-899.
2. van Besien K, Sobocinski KA, Rowlings PA et al. Allogeneic bone marrow transplantation for low-grade lymphoma. Blood 1998; 92: 1832-1836.
3. Freedman AS, Neuberg D, Mauch P et al. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood 1999; 94: 3325-3333.
4. Friedberg JW, Freedman AS. High-dose therapy and stem cell transplantation in follicular lymphoma. Ann Hematol 1999; 78: 203-211.
5. Mounier N, Socie G, Gisselbrecht C. High-dose therapy for indolent lymphoma. Crit Rev Oncol Hematol 2002; 41: 225-239.
6. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998; 16: 2780-2795.
7. Lin F, van Rhee F, Goldman JM et al. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 1996; 87: 4473-4478.
8. Dazzi F, Szydlo RM, Goldman JM. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand. Exp Hematol 1999; 27: 1477-1486.
9. Bagg A. Commentary: minimal residual disease: how low do we go? Mol Diagn 2001; 6: 155-160.
10. Hirt C, Dolken G. Quantitative detection of t(14; 18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation. Bone Marrow Transplant 2000; 25: 419-426.
11. Mandigers CM, Meijerink JP, Raemaekers JM et al. Graft-versus-lymphoma effect of donor leucocyte infusion shown by real-time quantitative PCR analysis of t(14; 18). Lancet 1998; 352: 1522-1523.
12. Keever-Taylor CA, Craig A, Molter M et al. Complement-mediated T-cell depletion of bone marrow: comparison of T10B9.1A-31 and Muromonab-Orthoclone OKT3. Cytotherapy 2001; 3: 467-481.
13. Corradini P, Astolfi M, Cherasco. C et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood 1997; 89: 724-731.
14. Meijerink JP, Goverde GJ, Smetsers TF et al. Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14; 18) in a patient before and after allogeneic bone marrow transplantation. Ann Oncol 1994; 5: 43-45.
15. Masuda R, Teshima T, Ishimaru F et al. Allogeneic peripheral blood stem cell transplantation for the treatment of refractory follicular lymphoma. Intern Med 1998; 37: 1050-1054.
16. Gribben JG, Neuberg D, Freedman AS et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449-3457.
17. Wittwer CT, Herrmann MG, Moss AA et al. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 1997; 22: 130-131, 134-138.